Literature DB >> 9174594

Does positive selection determine the B cell repertoire?

S Hachemi-Rachedi1, A Cumano, A M Drapier, P A Cazenave, P Sanchez.   

Abstract

To know whether each newly formed B cell has an equal chance of survival in the organism, we analyzed the composition of the B cell repertoire of extremely limited diversity by generating mu-transgenic kappa-knockout mice. Surprisingly, in both types of mice studied, the B cell repertoire is mainly composed of cells expressing the mu-transgene-encoded chain associated with only one out four available lambda types depending on the mu transgene. Moreover, B cell differentiation cultures in vitro show that newly formed B cells can express the various lambda types regardless of the presence or absence of the mu transgenes. These results show a drastic impact of the heavy chain on the lambda light chain repertoire expressed in the periphery. The overexpression of a unique heavy/light chain pairing therefore results from selective processes. The immature B cells may be positively selected to provide the immunocompetent B cells in the periphery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174594     DOI: 10.1002/eji.1830270505

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  A B-cell receptor-specific selection step governs immature to mature B cell differentiation.

Authors:  M H Levine; A M Haberman; D B Sant'Angelo; L G Hannum; M P Cancro; C A Janeway; M J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Alternative mechanisms of receptor editing in autoreactive B cells.

Authors:  Olga Kalinina; Colleen M Doyle-Cooper; Jennifer Miksanek; Wenzhao Meng; Eline Luning Prak; Martin G Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-06       Impact factor: 11.205

3.  Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool.

Authors:  M Turner; A Gulbranson-Judge; M E Quinn; A E Walters; I C MacLennan; V L Tybulewicz
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.